Al Shakarchi Julien, Day C, Inston N
1 Department of Renal Surgery, University Hospital Birmingham, Birmingham, UK.
2 Department of Renal Medicine, University Hospital Birmingham, Birmingham, UK.
J Vasc Access. 2018 Nov;19(6):593-595. doi: 10.1177/1129729818764135. Epub 2018 Mar 21.
: Home haemodialysis has been advocated due to improved quality of life. However, there are very little data on the optimum vascular access for it.
: A retrospective cohort study was carried on all patients who initiated home haemodialysis between 2011 and 2016 at a large university hospital. Access-related hospital admissions and interventions were used as primary outcome measures.
: Our cohort consisted of 74 patients. On initiation of home haemodialysis, 62 individuals were using an arteriovenous fistula as vascular access, while the remaining were on a tunnelled dialysis catheter. Of the 12 patients who started on a tunnelled dialysis catheter, 5 were subsequently converted to either an arteriovenous fistula ( n = 4) or an arteriovenous graft ( n = 1). During the period of home haemodialysis use, four arteriovenous fistula failed or thrombosed with patients continuing on home haemodialysis using an arteriovenous graft ( n = 3) or a tunnelled dialysis catheter ( n = 1). To maintain uninterrupted home haemodialysis, interventional rates were 0.32 per arteriovenous fistula/arteriovenous graft access-year and 0.4 per tunnelled dialysis catheter access-year. Hospital admission rates for patients on home haemodialysis were 0.33 per patient-year.
: Our study has shown that home haemodialysis can be safely and independently performed at home within a closely managed home haemodialysis programme. The authors also advocate the use of arteriovenous fistulas for this cohort of patients due to both low complication and intervention rates.
由于生活质量的提高,家庭血液透析受到了提倡。然而,关于其最佳血管通路的数据却非常少。
对一所大型大学医院2011年至2016年间开始进行家庭血液透析的所有患者进行了一项回顾性队列研究。与通路相关的住院和干预被用作主要结局指标。
我们的队列由74名患者组成。开始家庭血液透析时,62人使用动静脉内瘘作为血管通路,其余患者使用带隧道的透析导管。在开始使用带隧道透析导管的12名患者中,有5人随后转为使用动静脉内瘘(n = 4)或动静脉移植物(n = 1)。在家庭血液透析使用期间,4个动静脉内瘘失败或血栓形成,患者继续使用动静脉移植物(n = 3)或带隧道的透析导管(n = 1)进行家庭血液透析。为维持不间断的家庭血液透析,动静脉内瘘/动静脉移植物通路每年的干预率为0.32,带隧道的透析导管通路每年的干预率为0.4。家庭血液透析患者的住院率为每人每年0.33。
我们的研究表明,在一个管理严密的家庭血液透析项目中,家庭血液透析可以在家庭中安全、独立地进行。作者还提倡为这组患者使用动静脉内瘘,因为其并发症和干预率都很低。